Fingerprint
Dive into the research topics of 'A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically